Company-technologies-BMSystems or Bio-Modeling Systems: a leading Systems Biology / Integrative Biology company that delivers

What are CADI™ models? What are their specificities and competitive advantages?

Mechanisms of life being integrative non-linear processes, they require specific approaches to be correctly represented. CADI*™ models, belong to the non-mathematical holistic and heuristic class of models.
CADI™ modeling, innovative Systems Biology /Integrative Biology approach, is complementary to mathematical modeling approaches
The CADI™ models are detailed maps of inter-cellular and/or intra-cellular mechanisms associated with a biological status.
The CADI™ models can describe the dynamics of a pathological process and/or the pathological status vs. control.
CADI™ know-how and tools are independent of the “application/pathological domains”.
CADI™ models describe the mechanisms that cause the “problem” not only the consequences. They perform the necessary switch, analyzing diseases from a causal stand point, thereby abandoning the usual symptomatic approaches.
CADI™ models, due to this specificity, have led to novel, patentable discoveries in highly competitive applications
CADI™ models are the most efficient necessary step to define the contexts and the parameters to build local pertinent mathematical models
BMSystems does not sell its technologies nor access to its technologies

Computer-Assisted Deductive Integration (CADI™) proprietary methodologies and tools
CADI™ Search (data acquisition & mining)
CADI™ Architect (data organization & structuring)
CADI™ Fiber-N (integrative engine)
CADI™ View (model representation & visualization)
TAPE: A technology allowing to rapidly & simultaneously introduce defined densities of random mutations in any number of selected regions within a gene while conserving intact any number of defined coding domains in this same gene (applicable to all proteins, including antibodies, enzymes, etc..).,
AB-ACCUS: A recombination technology allowing the rapid & efficient production of phage banks in which every individual differs from all others for any number of selected genes or other sequences.
CNS (psychiatric disorders) new therapeutic strategies and preclinical evaluation platform patent, filed with CEA Life Sciences (September 10, 2008)

CEA (Atomic Energy Council. Life sciences unit) Fontenay-aux Roses: Department of prion and atypical infections research (SEPIA)
Pherecydes-Pharma: Antibacterial agents Biodefense & biosecurity spin-off (phages technologies)
ARD (Agro-industries Research & Development): leading Industrial Biotech research company in the industrial biotech world class cluster in France
IBT (Troyes Institute of Biotechnologies): Technological transfer institute
Formitel: Computing and internet company
Kayentis:The provider of the first “Digital Pen and Paper technology 2.0”, the universal platform delivering “contextualized” information .
BioXpr: The most diversified provider of Software solutions built from a versatile library of modules to create real-added value from “OMICS” datasets.